Granted Patent B2

US 12,415,031 · App. 17/703,313 · Granted Sep 16, 2025

Inventors: Dean Kamen (Bedford, NH); Larry B. Gray (Merrimack, NH); Richard J. Lanigan (Concord, NH); John Matthew Kerwin (Manchester, NH); Stephen Lewis Fichera (Salem, NH)

Assignee: DEKA PRODUCTS LIMITED PARTNERSHIP

A61M5/14248A61J1/20A61M5/1413A61M5/142A61M5/14212A61M5/14216A61M5/14224A61M5/14244A61M5/1452A61M5/14586A61M5/168A61M5/16804A61M5/16809A61M5/16831A61M5/172F04B7/00F04B43/02F04B43/09G01F22/00G05D7/0676A61B5/0024A61B5/1427A61B5/6833A61B2560/0412A61M2005/1402A61M2005/14208A61M2005/14252A61M2005/14268A61M2005/14506A61M5/158A61M2005/1583A61M2005/1585A61M2005/1586A61M5/162A61M5/16813A61M2005/16863A61M5/16886A61M5/1723A61M5/365A61M5/5086A61M2205/0266A61M2205/0294A61M2205/04A61M2205/16A61M2205/18A61M2205/3303A61M2205/3331A61M2205/3337A61M2205/3368A61M2205/3375A61M2205/3379A61M2205/3523A61M2205/3546A61M2205/3569A61M2205/3576A61M2205/3592A61M2205/50A61M2205/502A61M2205/52A61M2205/581A61M2205/582A61M2205/583A61M2205/6018A61M2205/8206A61M2205/8237A61M2206/22A61M2207/00A61M2209/045A61M2209/086A61M2230/201F04B43/1253G05B23/02G05D7/0647G08C17/02H04B7/2609Y10T29/49236Y10T29/494Y10T29/49412Y10T29/49826Y10T29/49828

Abstract

Claims (20)

1. A wearable infusion pump assembly comprising:

a reusable housing assembly;

a disposable housing assembly including a reservoir for receiving an infusible fluid;

a releasable engagement assembly configured to allow the reusable housing assembly to releasably engage the disposable housing assembly;

a bolus switch assembly configured to effectuate a bolus infusion event;

at least one processor; and

a computer readable medium coupled to the at least one processor, the computer readable medium including a plurality of instructions stored thereon which, when executed by the at least one processor, cause the at least one processor to perform operations comprising:

receiving an initiation signal from the bolus switch assembly indicative of a bolus infusion event;

receiving a dose signal from the bolus switch assembly indicative of at least a portion of a bolus quantity of the infusible fluid;

rendering an audible quantity signal in response to the dose signal; and

receiving an approval signal from the bolus switch assembly indicative of a concurrence with the audible quantity signal.

2. The wearable infusion pump assembly of claim 1 wherein the computer readable medium further includes instructions for:

administering the bolus quantity of the infusible fluid.

3. The wearable infusion pump assembly of claim 1 wherein the bolus switch assembly is configured to check a battery life of a battery of the reusable housing assembly.

4. The wearable infusion pump assembly of claim 3 wherein the bolus switch assembly is configured to check the battery life of the battery of the reusable housing assembly when the reusable housing assembly is disconnected from the disposable housing assembly and the bolus switch assembly is depressed for a defined period of time.

5. The wearable infusion pump assembly of claim 4 wherein the wearable infusion pump assembly renders a battery pass tone when the check of the battery life of the battery is determined to have a charge above a desired threshold.

6. The wearable infusion pump assembly of claim 4 wherein the wearable infusion pump wearable pump assembly renders a battery fail tone when the check of the battery life of the battery is determined to have a charge below a desired threshold.

7. The wearable infusion pump assembly of claim 1 wherein the bolus switch assembly is configured to cause pairing of the reusable housing assembly with a remote control assembly.

8. The wearable infusion pump assembly of claim 7 wherein the wearable infusion pump assembly is configured such that the reusable housing assembly is required to be uncoupled from the disposable housing assembly in order for the bolus switch assembly to cause the pairing of the reusable housing assembly with the remote control assembly.

9. The wearable infusion pump assembly of claim 1 wherein the bolus switch assembly is configured to cause aborting of administration of a bolus dose of the infusible fluid.

Assignments (1)

Continuity (13)

References Cited (400)